Blume was appointed to both the audit committee and the technology committee. Previously, Blume held the position of vice chairman for Deloitte, where she was a partner until retirement in 2015.
At Deloitte, Blume worked in a broad range of industries to transform business through the implementation of technology. Throughout her Deloitte career, she held numerous leadership positions, including serving as a member of the firm's US executive committee.
Centene provides a portfolio of services to government sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals.
Many receive benefits provided under Medicaid in addition to other state-sponsored programs, Medicare, dual eligible programs and programs with the US Department of Defense and US Department of Veterans Affairs.
The company also provides healthcare services to groups and individuals delivered through commercial health plans. It operates local health plans and offers a range of health insurance solutions.
Centene also contracts with other healthcare and commercial organizations to provide specialty services including behavioral health management, care management software, correctional healthcare services, dental benefits management, in-home health services, life and health management, managed vision, pharmacy benefits management, specialty pharmacy and telehealth services.
Futura Medical appoints Market Performance Group as new US distribution partner for Eroxon
MaaT Pharma to seek review after CHMP negative opinion on MaaT013 application
Sensei Biotherapeutics changes name to Faeth Therapeutics
Datavault AI and Wellgistics Health plan DelivMeds AI healthcare venture
Intensity Therapeutics receives Cancer Treatment Technology Innovator of the Year award
Solvonis Therapeutics appoints Water Tower Research to strengthen US market positioning
Atrium Therapeutics announces inducement grants to seven new employees
GXO appointed to manage NHS England bowel cancer home testing kits